Clinical Trials Logo

Filter by:
NCT ID: NCT03698097 Completed - Patient Survey Clinical Trials

Patient Surveys - What Patients Want

ch18Saxer
Start date: August 1, 2016
Phase:
Study type: Observational

This study is to gain insight into patients' preferences considering satisfaction surveys, specifically asking for their most pressing topics and their preferred survey technique.

NCT ID: NCT03698006 Completed - Postoperative Pain Clinical Trials

Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery

Start date: February 12, 2021
Phase: N/A
Study type: Interventional

Patient suffer from moderate posterior knee pain after TKA despite injection of local anesthetic around the femoral or saphenous nerves. Indeed, the posterior part of the knee is innervated by the sciatic nerve. This nerve is not routinely blocked as clinicians fear to produce a motor block of the leg that might impair the postoperative assessment. An analgesic alternative is the infiltration of the knee with local anesthetics performed by the surgeon. Recently a trial(1) demonstrated that a selective tibial nerve block provides an effective analgesia without a motor blockage when compared with a sciatic nerve block. The objective of this randomized controlled double-blinded trial is to assess whether a tibial nerve block is more effective for the postoperative pain than local infiltration analgesia when there are combined with an adductor canal block, without decreasing the functional parameters.

NCT ID: NCT03697512 Active, not recruiting - Clinical trials for Splenic Marginal Zone Lymphoma

MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas

MALIBU
Start date: September 27, 2019
Phase: Phase 2
Study type: Interventional

Single-arm, phase II clinical trial of patients with Extranodal Marginal Zone Lymphoma (EMZL). It is planned to recruit 130 patients. Additional patients with Splenic Marginal Zone Lymphoma (SMZL), up to 30, and Nodal Marginal Zone Lymphoma (NMZL), up to 15, will be included in the trial in order to preliminary explore the clinical activity and safety of the combination treatment proposed. The study primary endpoints will be analysed on the EMZL population. Outcome of patients with SMZL and NMZL will be analysed and reported separately

NCT ID: NCT03697213 Completed - Palliative Care Clinical Trials

The Surprise Study

Start date: March 25, 2019
Phase:
Study type: Observational

This study investigates the use of the Surprise Question [SQ] (would you be surprised if this patient were to die in the next 12 months?) in routine practice. In particular, the study will investigate the consistency of the responses to the SQ and the relationship with the subsequent course of action decided upon.

NCT ID: NCT03695731 Recruiting - Clinical trials for Diabetes Mellitus, Type 1

Influence of Diabetic Neuropathy on Activation of Brown Adipose Tissue

DIA-BAT
Start date: October 15, 2018
Phase: N/A
Study type: Interventional

Influence of diabetic neuropathy on cold induced brown adipose tissue in type 1 diabetic patients.

NCT ID: NCT03693885 Recruiting - Clinical trials for Respiratory Insufficiency Syndrome of Newborn

Oxytocin Administration Prior Planned Caesarean Section

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Spontaneous vaginal delivery of a healthy infant provokes a unique surge in stress hormone concentrations (e.g. AVP (arginine vasopressin) /copeptin) incommensurable with child or adult levels measured in any other situation. In contrast, infants delivered by primary caesarean section without preceding labour have low stress hormone concentrations at birth unless other stressors are present, including chorioamnionitis or intrauterine growth restriction. Infants delivered by caesarean section after a trial of labour show copeptin concentrations between these two extremes. Objectives:1) To reduce neonatal respiratory morbidity and admission to the Neonatal Intensive Care Unit and increase bonding and breastfeeding by triggering uterine contractions prior to planned caesarean delivery. 2) To collect prospectively weight data of infants in the first 6 months of life to validate and expand our online neonatal weight calculator. Study design: Open label; randomised, placebo controlled trail Intervention: Oxytocin challenge test (OCT): Infusion of oxytocin 5 IU/500 ml Ringer® lactate at a rate of 12 ml/h and doubled every 10 min until three uterine contractions per 10-min interval are induced, at which point it will be stopped. Primary endpoint: - Incidence of neonatal respiratory morbidity Secondary endpoints: - Umbilical cord blood copeptin levels - Postnatal neonatal weight change - Breastfeeding status

NCT ID: NCT03693755 Completed - Clinical trials for Catheter Complications

Dislocation Rates of Femoral Catheter Placed Sonographically Either In-plane or Out-of-plane

Start date: October 24, 2018
Phase: N/A
Study type: Interventional

Dislocation of the femoral nerve catheters, which are used as postoperative analgesic method after knie surgery, will be studied. Two Groups will be compared; in the first group the femoral nerve catheter will be placed sonographically with the in-plane technique, whereas in the other Group the femoral nerve catheter will be placed sonographically with the out-of-plane technique

NCT ID: NCT03692988 Completed - Depressive Disorder Clinical Trials

Dignity Therapy for Patients With Early Dementia and Their Family

DTD
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

Developed by Harvey M. Chochinov in 2005, Dignity Therapy (DT) invites individuals with life-limiting illnesses to reflect on matters of importance to them and compiles them in a narrative document for the patient to share. DT has shown to improve quality of life and a sense of dignity, as well as supporting relatives in the process of grievance. Featuring a gradual loss of memories of the past, decline of cognitive functions and awareness of self, dementia can be regarded as a life-limiting or life-changing illness, which is often accompanied by significant psychological stress. DT may help patients and their relatives reduce this stress. Yet, no studies have been conducted to determine the benefits of DT in patients with early stage dementia (ESD). This study investigates the feasibility and acceptance of DT by patients with (very) mild dementia (CDR: 0.5 - 1.5) and their relatives, as well as their overall satisfaction. This study further seeks to determine the effects of DT on sense of dignity, quality of life, dyadic coping, and levels of anxiety and depression in a randomized controlled design.

NCT ID: NCT03692962 Completed - Sleep Restriction Clinical Trials

Decision-making After Sleep Restriction

DM-SR
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

The aim of this project is to investigate whether enhancing sleep intensity locally in the prefrontal cortex (PFC) can counteract a deterioration of cognitive control and therefore the previously described increase in risk seeking during chronic sleep restriction. To this end, a controlled, counter-balanced study, consisting of two weeks of sleep restriction will be performed. During one of the sleep restriction weeks, sleep intensity in the PFC will be non-invasively enhanced by acoustic stimulation of slow waves during sleep.

NCT ID: NCT03692715 Recruiting - Nephrolithiasis Clinical Trials

Antibiotic Prophylaxis Before Shock Wave Lithotripsy

APPEAL
Start date: September 27, 2018
Phase: Phase 4
Study type: Interventional

This is a two arm, double blind RCT comparing the use of a single dose ciprofloxacin prior to SWL to saline alone. The multicenter trial will be conducted with a pragmatic emphasis including both high volume and low volume sites internationally.